Occupational Therapists in Safford, AZ Accepting Medicare

4 Occupational Therapists found. Showing 1 - 4

Dr. Daniel Leroy Gibbons, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 S 20th Ave, Bldg. E, Safford, AZ 85546 Phone: 928-651-5351

Mrs. Chrisitne Ann Marciniak, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9465 S Redbird Rd, Safford, AZ 85546 Phone: 928-428-4697

Lauren Noel Adams, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 S 20th Ave, Safford, AZ 85546 Phone: 928-348-4000

Christina Panasci Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 S 20th Ave, Safford, AZ 85546 Phone: 928-348-3888

News Archive

Obesity-related Quality-Adjusted Life Years lost by U.S. adults doubles from 1993 to 2008

Although the prevalence of obesity and obesity-attributable deaths has steadily increased, the resultant burden of disease associated with obesity has not been well understood. A new study published in the September issue of the American Journal of Preventive Medicine indicates that Quality-Adjusted Life Years (QALYs) lost to U.S. adults due to morbidity and mortality from obesity have more than doubled from 1993-2008 and the prevalence of obesity has increased 89.9% during the same period.

Two-meter COVID-19 rule is not a concrete measurement of safety, say researchers

A new study has shown that the airborne transmission of COVID-19 is highly random and suggests that the two-meter rule was a number chosen from a risk 'continuum', rather than any concrete measurement of safety.

Natus Medical reports increased revenue for 2009 fourth quarter

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

Preclinical studies show bladder cancers, mesotheliomas respond to treatment with ADI-PEG 20

Scientists from academic institutions reported at the 2013 annual American Association for Cancer Research meeting, results from preclinical studies which showed that certain bladder cancers and mesotheliomas have metabolic changes and are more likely to respond to treatment with ADI-PEG 20 (pegylated arginine deiminase) if they are deficient in the enzyme, argininosuccinate synthetase.

Read more Medical News

› Verified 6 days ago